Joanna Nakonieczna

Joanna Nakonieczna

Auto-generated profile, based on publicly available information

Joanna Nakonieczna

University of Gdańsk

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
ARAleksandra Rapacka-Zdończyk
Aleksandra Rapacka-Zdończyk
AWAgata Woźniak
Agata Woźniak
KSKlaudia Szymczak
Klaudia Szymczak
MPMichał Pierański
Michał Pierański
POPatrycja Ogonowska
Patrycja Ogonowska
JNJoanna Nakonieczna
Joanna Nakonieczna
Photodynamic inactivation of microorganisms (aPDI) is an excellent method to destroy antibiotic-resistant microbial isolates. The use of an exogenous photosensitizer or irradiation of microbial cells already equipped with endogenous photosensitizers makes aPDI a convenient tool for treating the infections whenever technical light delivery is possible. Currently, aPDI research carried out on a vast repertoire of depending on the photosensitizer used, the target microorganism, and the light delivery system shows efficacy mostly on in vitro models. The search for mechanisms underlying different responses to photodynamic inactivation of microorganisms is an essential issue in aPDI because one niche (e.g., infection site in a human body) may have bacterial subpopulations that will exhibit different susceptibility. Rapidly growing bacteria are probably more susceptible to aPDI than persister cells. Some subpopulations can produce more antioxidant enzymes or have better performance due to efficient efflux pumps. The ultimate goal was and still is to identify and characterize molecular features that drive the efficacy of antimicrobial photodynamic inactivation. To this end, we examined several genetic and biochemical characteristics, including the presence of individual genetic elements, protein activity, cell membrane content and its physical properties, the localization of the photosensitizer, with the result that some of them are important and others do not appear to play a crucial role in the process of aPDI. In the review, we would like to provide an overview of the factors studied so far in our group and others that contributed to the aPDI process at the cellular level. We want to challenge the question, is there a general pattern of molecular characterization of aPDI effectiveness? Or is it more likely that a photosensitizer-specific pattern of molecular characteristics of aPDI efficacy will occur?

11 January 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
POPatrycja Ogonowska
Patrycja Ogonowska
YGYolanda Gilaberte
Yolanda Gilaberte
WBWioletta Barańska-Rybak
Wioletta Barańska-Rybak
JNJoanna Nakonieczna
Joanna Nakonieczna
Atopic dermatitis (AD) patients are massively colonized withStaphylococcus aureus(S. aureus) in lesional and non-lesional skin. A skin infection may become systemic if left untreated. Of interest, the incidence of multi-drug resistantS. aureus(MRSA) in AD patients is higher as compared to a healthy population, which makes treatment even more challenging. Information on the specific genetic background ofS. aureusaccompanying and/or causing AD flares would be of great importance in terms of possible treatment option development. In this review, we summarized the data on the prevalence ofS. aureusin general in AD skin, and the prevalence of specific clones that might be associated with flares of eczema. We put our special interest in the presence and role of staphylococcal enterotoxins as important virulence factors in the epidemiology of AD-derivedS. aureus. Also, we summarize the present and potentially useful future anti-staphylococcal treatment.

29 March 2015 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
MGMariusz Grinholc
Mariusz Grinholc
JNJoanna Nakonieczna
Joanna Nakonieczna
GFGrzegorz Fila
Grzegorz Fila
ATAleksandra Taraszkiewicz
Aleksandra Taraszkiewicz
Anna KawiakAnna Kawiak
Anna Kawiak
KBKrzysztof Piotr Bielawski
Krzysztof Piotr Bielawski
A family of N-methylpyrrolidinium fullerene iodide salts has been intensively studied to determine their applicability in antimicrobial photodynamic therapy (APDT). This study examined in vitro the efficacy of a C60 fullerene functionalized with one methylpyrrolidinium group to kill upon irradiation with white light gram-negative and gram-positive bacteria, as well as fungal cells, and the corresponding mechanism of the fullerene bactericidal action. The in vitro studies revealed that the high antistaphylococcal efficacy of functionalized fullerene could be linked to their ability to photogenerate singlet oxygen and superoxide anion. Following Staphylococcus aureus photoinactivation, no modifications of its genomic DNA were detected. In contrast, photodamage of the cell envelope seemed to be a dominant mechanism of bactericidal action. In in vivo studies, a 2 log10 reduction in the average bioluminescent radiance between treated and non-treated mice was reached. One day post APDT treatment, moist and abundant growth of bacteria could be observed on wounds of non-fulleropyrrolidine and dark control mice. APDT-treated wounds stayed visibly clear up to the third day. Moreover, cytotoxicity test on human dermal keratinocytes revealed great safety of using the sensitizer toward eukaryotic cells. These data indicate potential application of functionalized fullerene as antistaphylococcal sensitizer for superficial infections.

20 August 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JNJoanna Nakonieczna
Joanna Nakonieczna
KWKatarzyna Wolnikowska
Katarzyna Wolnikowska
POPatrycja Ogonowska
Patrycja Ogonowska
DNDamian Neubauer
Damian Neubauer
ABAgnieszka Bernat
Agnieszka Bernat
Wojciech Kamysz, Pharm. D.Wojciech Kamysz, Pharm. D.
Wojciech Kamysz, Pharm. D.
Due to the overuse of antibiotics in medicine and food production, and their targeted mechanism of action, an increasing rate in spreading of antibiotic resistance genes has been noticed. This results in inefficient therapy outcomes and higher mortality all over the world. Pseudomonas aeruginosa (carbapenem-resistant) is considered one of the top three critical species according to the World Health Organization’s priority pathogens list. This means that new drugs and/or treatments are needed to tackle infections caused by this bacterium. In this context search for new/alternative approaches that would overcome resistance to classical antimicrobials is of prime importance. The use of antimicrobial photodynamic inactivation (aPDI) and antimicrobial peptides (AMPs) is an efficient strategy to treat localized infections caused by multidrug-resistant P. aeruginosa. In this study, we have treated P. aeruginosa cells photodynamically in the presence and in the absence of AMP (CAMEL or pexiganan). The conditions for aPDI were as follows: rose bengal (RB) as a photosensitizing agent at 1–10 μM concentration, and subsequent irradiation with 514 nm-LED at 23 mW/cm2 irradiance. The analysis of cell number after the treatment has shown that the combined action of RB-mediated aPDI and cationic AMPs reduced the number of viable cells below the limit of detection (<1log10 CFU/ml). This was in contrast to no reduction or partial reduction after aPDI or AMP applied separately. Students t-test was applied to test the statistical significance of the results. Noteworthy, our treatment proved to be effective against all 35 clinical isolates of P. aeruginosa tested within this study, including those characterized as multiresistant. Moreover, we demonstrated that such treatment is safe and does not violate the growth dynamics of human keratinocytes (77.3–97.64% survival depending on the concentration of the studied compounds or their mixtures).

1 October 2014 in Journal of Chromatography A
Verified
Journal Article
Closed access
Weronika Hewelt-BelkaWeronika Hewelt-Belka
Weronika Hewelt-Belka
JNJoanna Nakonieczna
Joanna Nakonieczna
MBMariusz Belka
Mariusz Belka
TBTomasz Baczek
Tomasz Baczek
JNJacek Namiesnik
Jacek Namiesnik
AKAgata Kot-Wasik
Agata Kot-Wasik

Verified
Journal Article
Open access
PDF file
ARAleksandra Rapacka-Zdończyk
Aleksandra Rapacka-Zdończyk
AWAgata Woźniak
Agata Woźniak
JNJoanna Nakonieczna
Joanna Nakonieczna
MGMariusz Grinholc
Mariusz Grinholc
Due to rapidly growing antimicrobial resistance, there is an urgent need to develop alternative, non-antibiotic strategies. Recently, numerous light-based approaches, demonstrating killing efficacy regardless of microbial drug resistance, have gained wide attention and are considered some of the most promising antimicrobial modalities. These light-based therapies include five treatments for which high bactericidal activity was demonstrated using numerous in vitro and in vivo studies: antimicrobial blue light (aBL), antimicrobial photodynamic inactivation (aPDI), pulsed light (PL), cold atmospheric plasma (CAP), and ultraviolet (UV) light. Based on their multitarget activity leading to deleterious effects to numerous cell structures—i.e., cell envelopes, proteins, lipids, and genetic material—light-based treatments are considered to have a low risk for the development of tolerance and/or resistance. Nevertheless, the most recent studies indicate that repetitive sublethal phototreatment may provoke tolerance development, but there is no standard methodology for the proper evaluation of this phenomenon. The statement concerning the lack of development of resistance to these modalities seem to be justified; however, the most significant motivation for this review paper was to critically discuss existing dogma concerning the lack of tolerance development, indicating that its assessment is more complex and requires better terminology and methodology.